Together with innovative organizations, we combine complementary expertise across biotech and life sciences to accelerate the development of new therapies for EB patients.
The EB RI team looks forward to hearing from you
The EB RI is dedicated to the development of new therapies for EB.
For full functionality of this page it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser
